Medical and pharmaceutical applications of mobile EEG (brain scanning)
-
Upload
andfaulkner -
Category
Health & Medicine
-
view
1.097 -
download
0
description
Transcript of Medical and pharmaceutical applications of mobile EEG (brain scanning)
04/09/2023 1
Personal Neuro Devices:Medical applications of
mobile EEG
04/09/2023 2
Electroencephalography (EEG)
04/09/2023 2
Reads brain activity
Neurofeedback therapy
Can track aspects of thought, emotion
04/09/2023
Mobile EEG
04/09/2023 3
Not bound to lab
Links to smartphone
Makes EEG monitoring available anywhere
Currently mostly for games
PND: mobile EEG software
04/09/2023 4
Mobile EEG beyond games
Treatment, diagnostics, self-monitoring
Team neuroscientists software engineers biomedical engineers business development
experts
04/09/2023 5
PND technologies: BackupBrain
Stores EEG info online
Accessible anywhere
Deeper analysis
04/09/2023 6
PND technologies: Amygdala
Backend for non-game mobile EEG software
Streamlines mobile EEG development
Algorithms, built-in GUIs, links to BackupBrain, etc.
Proof-of-concept: Transcend
Neurofeedback-based mobile meditation app
Comprehensive meditation tracking & analysis
Reads relaxation, concentration, meditation uses in-house algorithms
Introspect
EEG self-monitoring
Records mental states via EEG waveform analysis
Introspect
Example waveformslinked to mental states
Detects: (e.g.)
Mood
Anxiety
Stress
Acute cognitive functioning
Sleep quality
Concentration
Pain ‘unpleasantness’
04/09/2023 10
Introspect
Detects problem areas
Built-in neurofeedback exercises to improve specific areas
PND neurofeedback game: psych showdown
04/09/2023 11
Neurofeedback
Training to directly alter EEG output
Mindfulness-based Meditation
Effective treatment ADHD depression Anxiety etc.
PND: Pharmaceutical uses
Based on adaptations of Introspect
Introspect malleable for Research Diagnostics Treatment Etc.
PND: Pharmaceutical uses
1) New drug testing
mobile real-time drug efficacy monitoring
E.g. observe mood in brain over time
04/09/2023 14
PND: Pharmaceutical uses
2) Aid patient-specific drug selection
EEG patterns linked to disorder etiologies
Help hospital funding
04/09/2023 15
PND: Pharmaceutical uses
3) Monitor patient progress
Ensure continued symptom control
Change treatments as needed
Example mood and anxiety chart
04/09/2023 16
PND: Pharmaceutical uses
4) Augment treatments
Raise overall efficacy
Neurofeedback
04/09/2023 17
PND: Pharmaceutical uses
5) New class of as-needed meds
Alarm for impending “attack”
Preventative drug used upon alarm
PND: Pharmaceutical uses
6) Preventative medicine
Catch “slipping” mental health before disorder develops
04/09/2023 19
PND: Pharmaceutical uses
7) Diagnostics
Link day-to-day mental states to disorders
Reduce reliance on self-report
20
Thank you!
Any questions?
References• MacDonald, P. E., Rorsman, P. (2006). Oscillations, intercellular coupling, and insulin secretion in pancreatic beta
cells. PLoS Biol, 4(2): p49.• Tatum, W. O., Husain, A. M., Benbadis, S. R. (2008). Handbook of EEG Interpretation. Demos Medical Publishing.• Niedermeyer E. and da Silva F.L. (2004). Electroencephalography: Basic Principles, Clinical Applications, and Related
Fields. Lippincot Williams & Wilkins.• Rubboli, G., Parra, J., Seri, S., Takahashi, T., & Thomas, P. (2004). EEG diagnostic procedures and special investigations in
the assessment of photosensitivity. Epilepsia, 45(s1), p35-39.• Appleton, R., Macleod ,S., Martland ,T. (2008). Drug management for acute tonic-clonic convulsions including
convulsive status epilepticus in children. Cochrane Database of Systematic Reviews, 4: CD001905• Randell T. (2004). "Medical and legal considerations of brain death". Acta Anaesthesiologica Scandinavica 48 (2): 139–
144• Wijdicks EF. Determining brain death in adults. Neurology. 1995 May; 45(5): pp.1003-11• Kupfer, D. J., Foster, F. G., Coble, P., McPartland, R. J., and Ulrich, R. F. (1978). The application of EEG sleep for the
differential diagnosis of affective disorders Am J Psychiatry 1978; 135:69-74• Otto, K. A. (2008). EEG power spectrum analysis for monitoring depth of anaesthesia during experimental surgery; Lab
Anim , 42: pp. 45-61.• Sterman, M.B.; Friar, L. (1972). "Suppression of seizures in an epileptic following sensorimotor EEG feedback
training". Electroencephalogr Clin Neurophysiol 33 (1): 89–95• Basic concepts and clinical findings in the treatment of seizure disorders with EEG operant conditioning". Clin
Electroencephalogr 31 (1): 45–55.• Hammond, Corydon D. "Neurofeedback Treatment of Depression and Anxiety." Journal of Adult Development, Vol 12,
Nos. 2/3, August 2005• Gastaut, H. (1952). "Etude electrocorticographique de al reactivite des rhytmes rolandiques". Rev. Neurol 87 (2): 176–
182• Sny der et al. (2008). Blinded, multi-center val i da tion of EEG and rati ng scales in iden ti fy ing ADHD within a clin i cal sam
ple. Psy chi a try Research, 159, 346–358
References• Caat, M. T., Lorist, M. M., Bezdan, E., Roerdink, J. B., & Mauritis, N. M. (2008). High-Density EEG Coherence Analysis Using
Functional Units Applied to Mental Fatigue. Journal of Neuroscience Methods, 17, pp. 271-278.• Nuwer, M,, et al, (2005). Routine and Quantitative EEG in Mild Traumatic Brain Injury; Clinical Neurophysiology, 116.• Thatcher, R.W., Camacho, M,, Salazar, A, Linden, C., Biver, C. and Clarke, L.: Quantitative MRI of Gray-White Matter
Distribution in Traumatic Brain Injury. Journal of Neurotrauma, Volume 14, No. 1, 1-14, 1997• Thatcher, R.W., Moore, N, John, E.R., et al.: QEEG and Traumatic Brain Injury: Rebuttal of the American Academy of
Neurology 1997. A Report by the EEG and Clinical Neuroscience Society, Clinical Electroencephalography, 30(3): 94-98, 1999
• Khodayari-Rostamabad, A., Hasey, G. M., Maccrimmon, D. J., Reilly, J. P., & de Bruin, H. (2010). A pilot study to determine whether machine learning methodologies using pre-treatment electroencephalography can predict the symptomatic response to clozapine therapy. Clinical Neurophysiology, 121(12), 1998–2006
• Baskaran, A., Milev, R., & McIntyre, R. S. (2012). The neurobiology of the EEG biomarker as a predictor of treatment response in depression. Neuropharmacology, 63(4), 507–13
• Thompson, L. et al (2010). Neurofeedback outcomes in clients with Asperger’s syndrome. Applied psychophysiology and biofeedback, 35(1), 63–8
• Kouijzer, M., et al. (2009). Neurofeedback Treatment for Autism Spectrum Disorders: Scientific Found- ations and Clinical Practice. Autism Spectrum Disorders – From Genes to Environment (p. 101–122)
More available on request